A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a multicenter study to evaluate the safety and efficacy of ezetimibe/simvastatin versus rosuvastatin in participants with high cholesterol.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Calcium; Ezetimibe; Ezetimibe, Simvastatin Drug Combination; Rosuvastatin Calcium; Simvastatin

Criteria

Inclusion Criteria:

• Participant is currently taking a statin medication for the treatment of high cholesterol

• Participant has an LDL-C level that is greater than or equal to 100 mg/dl and less than or equal to 190 mg/dl

Exclusion Criteria:

• Women who are pregnant or nursing, or women who intend to become pregnant

• Participant has any condition, situation, or is currently taking any medication that might pose a risk to the participant or interfere with participation in the study